Member Info for EarlofAim

Contango Holdings PLC

("Contango" or the "Company")

Statement re Share Price Movement

Contango Holdings Plc, the producing London listed natural resource development company, notes the share price movement and provides the following update regarding corporate activity and an operational update.

Potential Asset Sale

The Company has received a non-binding proposal for the potential acquisition of its assets which may results in the sale of its assets at the subsidiary

Lots of companies getting bought out

look at MCM, coal producer, Rns out to buy

Contango Holdings has Met coal, always in demand.

I reckon Chinese companies bidding to buy CGO

20p = £100m

with asset over £2b this 20p offer is consecutively low

met coal always in demand for the steel industry!!

ivre

Another coal company had a offer MCM

CGO looks like next one for take over

Takeover Imminent,

20p minimum

Yes I agree Chris,

AI tech for the medical sector will be massive as new illness starts to emerge and AI will have access to all the disease humankind had in the past, so Machine Learning ML and Artificial intelligence AI both will become industry norm and Fusion Antibodies are ahead of the curve.

GLA and Dyor

Https://healthcare-digital.com/technology-and-ai/global-ai-safety-summit-bupas-cto-calls-for-framework

AI summit

Rishi Sunak to put £100m to AI companies

fusion Antibody should benefit as it's AI driven

Cashed up till 2024 April

With the surging interest in the application of AI to biotech, is Fusion Antibodies in the right place at the right time?

“…The company is positioning itself to ride a wave of investment in biotech AI applications which promise to transform the notoriously slow process of drug discovery…”

Like the wider small cap biotech sector Fusion Antibodies (AIM:FAB) has had a challenging 18 months, its price tumbling from more than 150p to less than 10p today. But with signs that the high interest rates that have been so damaging for growth shares may have peaked, and a business model oriented towards the AI technologies set to sweep through the biotech sector, now may be the time to take a fresh look at a share that was riding high not so very long ago.

Use twitter to post this

Https://total-market-solutions.com/2023/08/fusion-antibiotics-plc/

#fab @fsnantibodies

#Aisummit

breakthrough in medical sector

Https://total-market-solutions.com/2023/08/fusion-antibiotics-plc/

Not many know what FAB Fusion Antibodies do, maybe with the AI exposure today, investors will appreciate the work Fusion Antibodies are doing

Mcap only £3m could easily become £50m with the right deals

Https://gadgetshowtech.com/first-ever-ai-summit-held-in-uk-today-joined-by-elon-musk/

Today the government has announced investment in the new ‘AI Research Resource’

#Aisummit day 2

This is a big event happening in the UK

list of people attending are leaders in their field

Https://www.google.com/amp/s/www.cnbc.com/amp/2023/11/01/elon-musk-in-the-uk-for-ai-summit-heres-whos-goingf.html

***Elon Musk is in the UK for a pivotal summit on AI — here's who's going

PUBLISHED WED, NOV

New York State Comptroller Tom DiNapoli is doubling down on his support for local companies by pledging an additional $50m in investment funds from the New York State pension kitty.

The Comptroller is the sole trustee of the $250bn New York state's Retirees' Fund and has previously made investments in a raft of successful Belfast businesses including Andor Technologies, Datactics and Fusion Antibodies of Poleglass.

New York State Comptroller Tom DiNapoli is doubling down on his support for local companies by pledging an additional $50m in investment funds from the New York State pension kitty.

The Comptroller is the sole trustee of the $250bn New York state's Retirees' Fund and has previously made investments in a raft of successful Belfast businesses including Andor Technologies, Datactics and Fusion Antibodies of Poleglass.